28 Mar 2017 11:36
Zotefoams plc (the 'Company')
Directors' Shareholdings
The Company announces that on 27 March 2017 the Executive Directors were granted the following restricted share awards over the Company's Ordinary Shares of 5p each under the Company's Deferred Bonus Share Plan ('DBSP'):
Number of Shares | Release Date | Share Scheme | |
D B Stirling | 10,061 | 27 March 2020 | DBSP |
G C McGrath | 6,533 | 27 March 2020 | DBSP |
The DBSP awards will be released on the third anniversary of the grant of the awards following the satisfaction of the service conditions.
In addition to the above-mentioned awards, the Executive Directors hold the following awards over the Company's Ordinary Shares of 5p each:
Director | Number of Shares | Exercise Period | ExercisePrice (p) | Share Scheme |
D B Stirling | 28,116 | 12/08/11-11/08/18 | 106.7 | ASOP |
32,346 | 07/04/17 onwards | Nil | LTIP | |
73,880 | 30/03/18 onwards | Nil | LTIP | |
74,507 | 05/04/19 onwards | Nil | LTIP | |
8,150 | 30/03/18 onwards | Nil | DBSP | |
8,278 | 05/04/19 onwards | Nil | DBSP | |
212 | - | - | SIP | |
G C McGrath | 10,344 | 05/04/19-04/04/26 | 290.0 | ASOP |
48,426 | 05/04/19 onwards | Nil | LTIP | |
164 | - | - | SIP |
LTIP denotes the Company's Long-Term Incentive Plan. ASOP denotes the Company's Approved Share Option Plan. SIP denotes the Company's Share Incentive Plan and the figures disclosed relate to Matching Shares awards held in the SIP.
The Notification of Dealing Form for each Executive Director can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Enquiries:
James Kindell
Company Secretary
Zotefoams plc
28 March 2017
020 8664 1600
About Zotefoams plc:
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTE® polyolefin and ZOTEK® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®).
www.zotefoams.com
AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc
MuCell® is a registered trademark of Trexel Inc.
ZOTEFOAMS PLC
DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
1. | Details of the person discharging managerial responsibilities/person closely associated | ||||||
a) | Name: David Stirling | ||||||
2. | Reason for the notification | ||||||
a) | Position/status: Group CEO | ||||||
b) | Initial notification/Amendment: Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
a) | Name: Zotefoams plc | ||||||
b) | LEI: 213800B6P256B5XN8D32 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 | ||||||
b) | Nature of the transaction: Award of restricted shares under the Deferred Bonus Share Plan | ||||||
c) | Price(s) and volume(s):
| ||||||
d) | Aggregated information:
| ||||||
e) | Date of the transaction: 2017-03-27 | ||||||
f) | Place of the transaction: Outside a trading venue |
ZOTEFOAMS PLC
DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
1. | Details of the person discharging managerial responsibilities/person closely associated | ||||||
a) | Name: Gary McGrath | ||||||
2. | Reason for the notification | ||||||
a) | Position/status: Finance Director | ||||||
b) | Initial notification/Amendment: Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
a) | Name: Zotefoams plc | ||||||
b) | LEI: 213800B6P256B5XN8D32 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument, type of instrument: Ordinary shares of 5 pence each Identification code: GB0009896605 | ||||||
b) | Nature of the transaction: Award of restricted shares under the Deferred Bonus Share Plan | ||||||
c) | Price(s) and volume(s):
| ||||||
d) | Aggregated information:
| ||||||
e) | Date of the transaction: 2017-03-27 | ||||||
f) | Place of the transaction: Outside a trading venue |
Zotefoams (ZTF)